Transdermal Delivery of Low-Molecular-Weight Drugs and New Modality of Drugs: Recent Innovation to Penetration Enhancement Techniques
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 20 April 2025 | Viewed by 764
Special Issue Editors
2. Faculty of Pharmaceutical Sciences, Josai International University, 1 Gumyo Togane, Chiba 283-0002, Japan
3. Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, 1-1 Keyakidai Sakado, Saitama 350-0295, Japan
Interests: pharmaceutical technology; drug delivery; skin permeation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The current diversification of drug discovery methods has sparked a revolution in technologies for seeking active pharmaceutical ingredients. Simultaneously, the developments in drug administration methods form new modalities and low-molecular-weight drugs. Consequently, there is a growing need to establish methodologies that facilitate easy administration, particularly for children and patients with dementia. If sufficient quantities of drugs, including medium-sized molecules, can be effectively administered through the skin, it could significantly advance overall drug therapy. For this Special Issue, we encourage scientists worldwide to propose innovations in penetration enhancement techniques that enable transdermal delivery not only for small molecules, but also for medium-sized drugs.
Prof. Dr. Kenji Sugibayashi
Dr. Takeshi Oshizaka
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- transdermal delivery
- enhanced skin permeation
- penetration enhancer
- microneedle
- iontophoresis
- new modality
- easy administration
- skin barrier
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
